Search

everythinglearnresearchcommunity

for

Search:↓

Diane® is an effective contraceptive that also helps treat acne and mild hair growth issues.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

The combination therapy effectively treats infertility in PCOS without major side effects.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Some birth control pills have a higher risk of blood clots than others.

High doses of ethynylestradiol in rats caused growth issues, organ changes, and some tumors, but didn't increase overall tumor rates.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

The combination treatment didn't work better than minoxidil alone and caused more menstrual issues.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Some birth control pills increase blood clot risk; use them for specific conditions only.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Two women had skin reactions from a hair loss treatment and got better after stopping use.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Hormonal contraceptives are highly effective but require medical evaluation due to potential health risks.